BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 4429641)

  • 1. Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF).
    Ly B; Kierulf P; Jakobsen E
    Thromb Res; 1974 Apr; 4(4):509-22. PubMed ID: 4429641
    [No Abstract]   [Full Text] [Related]  

  • 2. Incorporation of fibrinogen into soluble fibrin complexes.
    Jakobsen E; Ly B; Kierulf P
    Thromb Res; 1974 Apr; 4(4):499-507. PubMed ID: 4428463
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of soluble, FSF-stabilized fibrin complexes with special reference to the role of fibrinogen.
    Ly B; Kierulf P; Jakobsen E; Gravem K
    Thromb Res; 1974 Jul; 5(1):21-32. PubMed ID: 4428469
    [No Abstract]   [Full Text] [Related]  

  • 4. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes.
    Brosstad F
    Thromb Res; 1979; 15(3-4):563-8. PubMed ID: 40318
    [No Abstract]   [Full Text] [Related]  

  • 6. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():149-54. PubMed ID: 4629549
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of human plasma fibrin stabilizing factor (factor XIII) from fibrinogen by fibrinogen polymer formation.
    Becker CM
    Biochem Biophys Res Commun; 1986 Jan; 134(2):678-84. PubMed ID: 3947344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
    Okude M; Yamanaka A; Morimoto Y; Akihama S
    Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography.
    Ng AS; Lewis SD; Shafer JA
    Methods Enzymol; 1993; 222():341-58. PubMed ID: 8412803
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA; Halver JE; Gladner JA
    Biochem Biophys Res Commun; 1973 Oct; 54(3):849-55. PubMed ID: 4148128
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
    von Hugo R; Stemberger A; Graeff H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-linking of actin and fibrin by fibrin-stabilizing factor.
    Mui PT; Ganguly P
    Am J Physiol; 1977 Sep; 233(3):H346-9. PubMed ID: 910923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin.
    Lorand L
    Ann N Y Acad Sci; 2001; 936():291-311. PubMed ID: 11460485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.